Related Experiment Videos
Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan
Kazufumi Nagahama1, Kunitoshi Iseki, Taku Inoue
1Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus, Okinawa, Japan. YHK03103@nifty.ne.jp
Insights
High serum uric acid levels are linked to increased cardiovascular risks like obesity and hypertension in both men and women. Hyperuricemia is associated with a clustering of these risk factors, highlighting its importance in cardiovascular health.
Area of Science:
- Cardiovascular Health
- Metabolic Syndrome
- Clinical Biochemistry
Background:
- The relationship between serum uric acid levels and cardiovascular risk factors is complex and primarily studied in men.
- Understanding this association in both genders is crucial for comprehensive cardiovascular risk assessment.
Purpose of the Study:
- To investigate the correlation between serum uric acid levels and key cardiovascular risk factors including obesity, hypertension, dyslipidemia, and diabetes mellitus (DM).
- To examine these associations in a large cohort of both men and women in Okinawa, Japan.
Main Methods:
- Analysis of data from 9,914 individuals (6,163 men, 3,751 women) screened at the Okinawa General Health Maintenance Association.
- Hyperuricemia defined as serum uric acid ≥7.0 mg/dl (men) and ≥6.0 mg/dl (women).
- Calculation of odds ratios for hyperuricemia in relation to obesity, hypertension, hypercholesterolemia, hypertriglyceridemia, hypo-HDL cholesterolemia, and DM.
Main Results:
- Hyperuricemia showed positive associations with obesity, hypertension, hypercholesterolemia, and hypertriglyceridemia in both men and women.
- Hyperuricemic subjects exhibited a higher prevalence of coexisting cardiovascular risk factors compared to non-hyperuricemic individuals.
- A significant clustering of cardiovascular risk factors was observed in hyperuricemic individuals.
Conclusions:
- Hyperuricemia is positively associated with obesity, hypertension, and dyslipidemia in both genders.
- Hyperuricemic individuals are more likely to present with a clustering of cardiovascular risk factors.
- These findings emphasize the role of hyperuricemia as a potential marker for increased cardiovascular risk.
Abstract:
The relation between serum uric acid level and cardiovascular risk factors is complex and has been investigated mainly in men. We examined the correlation between serum uric acid level and obesity, hypertension, dyslipidemia, and diabetes mellitus (DM) in both men and women of a screened cohort in Okinawa, Japan. A total of 9,914 individuals (6,163 men and 3,751 women ranging in age from 18 to 89 years) who were screened at Okinawa General Health Maintenance Association were subjects in this study. Hyperuricemia was defined as a serum uric acid level > or = 7.0 mg/dl in men and > or = 6.0 mg/dl in women. The odds ratios (95% confidence intervals) for the presence of hyperuricemia in men were 1.75 (1.56-1.97) for obesity, 1.42 (1.25-1.62) for hypertension, 1.16 (1.02-1.30) for hypercholesterolemia, 1.80 (1.60-2.03) for hypertriglyceridemia, 1.19 (1.02-1.40) for hypo-high density lipoprotein (HDL) cholesterolemia, and 0.61 (0.49-0.75) for DM; in women, they were 2.02 (1.62-2.53) for obesity, 1.64 (1.29-2.10) for hypertension, 1.31 (1.04-1.65) for hypercholesterolemia, 1.95 (1.51-2.51) for hypertriglyceridemia, 1.53 (0.96-2.44) for hypo-HDL cholesterolemia, and 1.20 (0.76-1.90) for DM. Hyperuricemic subjects had higher rates of coexistence of two or more of these cardiovascular risk factors than non-hyperuricemic subjects (63.8% vs. 43.2% in men; 58.9% vs. 27.6% in women). The present study revealed that hyperuricemia is positively associated with obesity, hypertension, and dyslipidemia in both men and women, and that hyperuricemic subjects tend to have a clustering of these cardiovascular risk factors.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures
Hypertension III: Clinical Manifestations and Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Chronic Kidney Disease II: Clinical Manifestations